Skip to Main Content

Paper Details

Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Metabolites
2
2022
C16:, C3-DC-CH3 carnitine, C38:4 PI, C5, Cancer, Prostate, Lung, Colorectal, and Ovarian Cancer, RCC, RCCs, Renal Cell Carcinoma, alcohol, carnitine, diabetes, hypertension, kidney cancers, malignancy, metabolic dysfunction, renal cell carcinomas
Author NameAffiliation
Kathleen M McClainNational Cancer Institute
Robert E GersztenBeth Israel Deaconess Medical Center
Clary B ClishBroad Institute of MIT and Harvard
Clary B ClishBroad Institute of MIT and Harvard
Loren LipworthVanderbilt University Medical Center
  • 1 - 5

Datasets

Release 1.2